Enveda Therapeutics, Inc. announced that it has received $55 million in a round of funding on June 14, 2024. The transaction included participation from new investors, PremjiInvest, Lingotto Investment Management LLP, Microsoft Corporation, The Nature Conservancy, returning investors, Kinnevik AB, True Venture Management, LLC, FPV Ventures, LLC, Level Ventures and Jazz Venture Partners, L.P. The company has raised a total of $230 million in funding till date.